| Nome |
# |
|
Systematic review of photobiomodulation for the managementof oral mucositis in cancer patients and clinical practice guidelines, file ddc633e3-cc0b-4e2e-e053-3705fe0a4c80
|
2.121
|
|
The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing, file ddc633e4-1344-4e2e-e053-3705fe0a4c80
|
1.568
|
|
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents, file ddc633e3-fd32-4e2e-e053-3705fe0a4c80
|
1.073
|
|
Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients, file ddc633e4-04ea-4e2e-e053-3705fe0a4c80
|
547
|
|
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma, file ddc633e4-30fb-4e2e-e053-3705fe0a4c80
|
512
|
|
Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE study, file ddc633e4-1e66-4e2e-e053-3705fe0a4c80
|
479
|
|
Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio, file ddc633e3-c6a4-4e2e-e053-3705fe0a4c80
|
129
|
|
Patterns of recurrences in sinonasal cancers undergoing an endoscopic surgery-based treatment: Results of the MUSES* on 940 patients: *MUlti-institutional collaborative Study on Endoscopically treated Sinonasal cancers, file acdf5aa5-000b-4078-a1df-0fbbc527132d
|
128
|
|
Tumor biomarkers for the prediction of distant metastasis in head and neck squamous cell carcinoma, file ddc633e4-1d97-4e2e-e053-3705fe0a4c80
|
126
|
|
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets, file ddc633e4-4fbd-4e2e-e053-3705fe0a4c80
|
109
|
|
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways, file ddc633e4-24c2-4e2e-e053-3705fe0a4c80
|
106
|
|
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions, file ddc633e4-1342-4e2e-e053-3705fe0a4c80
|
100
|
|
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma, file ddc633e4-25a9-4e2e-e053-3705fe0a4c80
|
98
|
|
Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives, file ddc633e4-5bdc-4e2e-e053-3705fe0a4c80
|
98
|
|
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma, file ddc633e4-3436-4e2e-e053-3705fe0a4c80
|
94
|
|
Malnutrition management in oncology: An expert view on controversial issues and future perspectives, file 850747bb-c850-48b6-95f1-ab45d705fc9d
|
90
|
|
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements., file ddc633e3-ed12-4e2e-e053-3705fe0a4c80
|
87
|
|
Addressing the quality of life needs of older patients with cancer: A SIOG consensus paper and practical guide, file ddc633e4-6673-4e2e-e053-3705fe0a4c80
|
84
|
|
Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines, file ddc633e4-6393-4e2e-e053-3705fe0a4c80
|
81
|
|
The efficacy of immunonutrition in improving tolerance to chemoradiotherapy in patients with head and neck cancer, receiving nutritional counseling: study protocol of a randomized, open-label, parallel group, bicentric pilot study, file ddc633e4-671b-4e2e-e053-3705fe0a4c80
|
81
|
|
The association between Vitamin D and gut microbiota: A systematic review of human studies, file ddc633e4-5a6c-4e2e-e053-3705fe0a4c80
|
80
|
|
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients, file ddc633e4-2648-4e2e-e053-3705fe0a4c80
|
78
|
|
The Burning Question: Prophylactic Gabapentin for Mucositis-Related Pain in Patients Undergoing Chemoradiation Therapy for Head and Neck Cancer?, file ddc633e4-6f59-4e2e-e053-3705fe0a4c80
|
68
|
|
The use of fentanyl in pain management in head and neck cancer patients: a narrative review, file ddc633e4-631c-4e2e-e053-3705fe0a4c80
|
66
|
|
Clinical use of photobiomodulation for the prevention and treatment of oral mucositis: the real-life experience of MASCC/ISOO members, file ce80715c-0195-46d5-a401-c5a7162d4e97
|
64
|
|
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development, file ddc633e4-20b4-4e2e-e053-3705fe0a4c80
|
64
|
|
Overview of oral potentially malignant disorders: From risk factors to specific therapies, file ddc633e4-5cbe-4e2e-e053-3705fe0a4c80
|
63
|
|
Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases, file ddc633e4-5670-4e2e-e053-3705fe0a4c80
|
60
|
|
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study, file ddc633e4-6279-4e2e-e053-3705fe0a4c80
|
59
|
|
Prognostic significance of cd4+ and cd8+ tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: A meta-analysis, file ddc633e4-3e08-4e2e-e053-3705fe0a4c80
|
57
|
|
Sinonasal squamous cell carcinoma, a narrative reappraisal of the current evidence, file ddc633e4-5abb-4e2e-e053-3705fe0a4c80
|
49
|
|
Immunotherapy in nonendemic nasopharyngeal carcinoma: Real-world data from two nonendemic regions, file ddc633e4-6f57-4e2e-e053-3705fe0a4c80
|
49
|
|
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic, file ddc633e4-6246-4e2e-e053-3705fe0a4c80
|
47
|
|
Prognostic Nutritional Index: An easy nutritional screening for patients with head and neck cancer?, file ddc633e4-5cc8-4e2e-e053-3705fe0a4c80
|
46
|
|
Prognostic value of H-index in patients surgically treated for squamous cell carcinoma of the larynx, file ddc633e4-5de6-4e2e-e053-3705fe0a4c80
|
46
|
|
The role of benzydamine in prevention and treatment of chemoradiotherapy-induced mucositis, file ddc633e4-5e17-4e2e-e053-3705fe0a4c80
|
46
|
|
Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer, file ddc633e4-5cc4-4e2e-e053-3705fe0a4c80
|
44
|
|
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial, file ddc633e4-5c1f-4e2e-e053-3705fe0a4c80
|
43
|
|
Nutrition in patients with cancer: A new area for medical oncologists? A practising oncologist's interdisciplinary position paper, file ddc633e4-608b-4e2e-e053-3705fe0a4c80
|
43
|
|
What to do and what not to do in the management of cancer pain: A physician survey and expert recommendations, file ddc633e4-65b8-4e2e-e053-3705fe0a4c80
|
42
|
|
The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: A narrative review, file ddc633e4-5de8-4e2e-e053-3705fe0a4c80
|
40
|
|
Vitamin D supplementation and cancer mortality: Narrative review of observational studies and clinical trials, file ddc633e4-62b5-4e2e-e053-3705fe0a4c80
|
39
|
|
Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives, file ddc633e4-6fea-4e2e-e053-3705fe0a4c80
|
39
|
|
Editorial: Advances in the Multidisciplinary Management of Oral Cancer, file ddc633e4-5f85-4e2e-e053-3705fe0a4c80
|
38
|
|
Transformation of Cancer Care during and after the COVID Pandemic, a point of no return. The Experience of Italy, file ddc633e4-5fa4-4e2e-e053-3705fe0a4c80
|
38
|
|
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial, file 7d17a536-56c5-466f-8e35-218df8b0aa67
|
36
|
|
Recurrent/metastatic squamous cell carcinoma of the head and neck: A big and intriguing challenge which may be resolved by integrated treatments combining locoregional and systemic therapies, file ddc633e4-6120-4e2e-e053-3705fe0a4c80
|
36
|
|
Refining Tumor Treatment in Sinonasal Cancer Using Delta Radiomics of Multi-Parametric MRI after the First Cycle of Induction Chemotherapy, file ddc633e4-6f5a-4e2e-e053-3705fe0a4c80
|
35
|
|
Salvage surgery in recurrent sinonasal cancers: Proposal for a prognostic model based on clinicopathologic and treatment-related parameters, file 2e2e90d3-50dc-42fa-91db-a3a833ae18f1
|
34
|
|
Advanced lung cancer inflammation index and its prognostic value in HPV-negative head and neck squamous cell carcinoma: a multicentre study, file ddc633e4-5962-4e2e-e053-3705fe0a4c80
|
34
|
|
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial, file ddc633e4-4d0f-4e2e-e053-3705fe0a4c80
|
32
|
|
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders, file ddc633e4-65f0-4e2e-e053-3705fe0a4c80
|
32
|
|
A randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy of Aqualief™ mucoadhesive tablets in head and neck cancer patients who developed radiation-induced xerostomia, file ddc633e4-5afd-4e2e-e053-3705fe0a4c80
|
28
|
|
Not all hematopoietic growth factors are created equal: Should we gain information for their use with immunotherapy?, file ddc633e4-671d-4e2e-e053-3705fe0a4c80
|
26
|
|
Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022, file 5323863e-3f58-415d-9746-557624e118e0
|
23
|
|
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, file e3da00a3-4db0-4bb7-8f34-7efaf13d2c43
|
23
|
|
Different inflammatory blood markers correlate with specific outcomes in incident HPV-negative head and neck squamous cell carcinoma: a retrospective cohort study, file ddc633e4-6899-4e2e-e053-3705fe0a4c80
|
20
|
|
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel, file 995ba39f-2e7d-4e90-8563-8e83b79b019e
|
18
|
|
The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts, file ddc633e4-686f-4e2e-e053-3705fe0a4c80
|
18
|
|
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy, file ddc633e4-671e-4e2e-e053-3705fe0a4c80
|
17
|
|
Rapid-Onset Opioids for Management of Breakthrough Cancer Pain: Considerations for Daily Practice, file f44bc3e5-2328-484c-a51c-6557effdc03c
|
17
|
|
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer, file 201a3d6b-e386-4233-b50a-988884fe08b7
|
15
|
|
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study, file eeac2dd5-94fb-4be9-965d-fbc3a99c1c85
|
14
|
|
Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic review, file a3dc087a-4417-4f8f-b8c1-37f0f387d243
|
13
|
|
Treatment of cutaneous squamous cell carcinoma with immune checkpoint inhibitors in special populations, file ddc633e4-683c-4e2e-e053-3705fe0a4c80
|
13
|
|
Confounding factors in the assessment of oral mucositis in head and neck cancer, file 011b68ab-350d-4b7a-8638-2793f828864f
|
12
|
|
Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group, file ddc633e4-6871-4e2e-e053-3705fe0a4c80
|
12
|
|
Corrigendum to "Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma" [Eur J Canc 157 (2021) 250-258], file 1f5ecf27-f99b-4ebf-8e0b-b012514f9a18
|
11
|
|
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders, file 29427f2e-7f57-400f-b580-eb270926bb0e
|
11
|
|
Unmet Needs and Perspectives in Oral Cancer Prevention, file 93d19bdf-cd91-4e82-81c4-ca48d8b2cd93
|
10
|
|
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases, file 95f34938-1541-4885-94b0-17738ca8073c
|
10
|
|
Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis, file d1ec1fcb-8f36-4812-8c2e-c467a33cc70e
|
10
|
|
Nutritional Support in Cancer patients: update of the Italian Intersociety Working Group practical recommendations, file f09e45f2-e6ff-4777-9a65-004230649b7a
|
10
|
|
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways, file b4e7aafa-3eb1-4246-aa8c-838f56f663d1
|
6
|
|
Personalized Medicine in Skull Base and Sinonasal Tumors, file 0854f2da-2613-414d-8a1c-7bf7e3920a2c
|
5
|
|
Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio, file ddc633e3-c6a5-4e2e-e053-3705fe0a4c80
|
5
|
|
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement, file ddc633e3-25d0-4e2e-e053-3705fe0a4c80
|
4
|
|
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR, file 6767cf7e-ca10-4df7-836c-43568ec5d2f9
|
2
|
|
Cetuximab in the management of nasopharyngeal carcinoma - A narrative review, file ddc633e4-6514-4e2e-e053-3705fe0a4c80
|
2
|
|
Comparison of platinum-based regimens in combination with radiotherapy for head and neck cancers: A network meta-analysis, file 94f0d825-06ce-4a6c-980b-72ec9fb89f63
|
1
|
|
Treatment de-escalation for HPV+ oropharyngeal cancer: A systematic review and meta-analysis, file 99b221ec-dd08-4a52-8de7-935fe59bf332
|
1
|
|
Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer, file ddc633e3-c0b3-4e2e-e053-3705fe0a4c80
|
1
|
|
Management of sinonasal adenocarcinomas with anterior skull base extension, file ddc633e4-59ba-4e2e-e053-3705fe0a4c80
|
1
|
|
Sinonasal cancers treatments: state of the art, file ddc633e4-59d8-4e2e-e053-3705fe0a4c80
|
1
|
|
Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort, file ddc633e4-5aa5-4e2e-e053-3705fe0a4c80
|
1
|
|
Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials, file ddc633e4-5cc6-4e2e-e053-3705fe0a4c80
|
1
|
|
In Reply to Fakhry et al, file ddc633e4-5cca-4e2e-e053-3705fe0a4c80
|
1
|
|
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: An alternative approach for overcoming potential bias, file ddc633e4-5d3e-4e2e-e053-3705fe0a4c80
|
1
|
|
Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients, file ddc633e4-5d40-4e2e-e053-3705fe0a4c80
|
1
|
|
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation, file ddc633e4-5d67-4e2e-e053-3705fe0a4c80
|
1
|
|
The pathogenesis of mucositis: updated perspectives and emerging targets, file ddc633e4-5d6c-4e2e-e053-3705fe0a4c80
|
1
|
|
Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial, file ddc633e4-5e22-4e2e-e053-3705fe0a4c80
|
1
|
|
Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients, file ddc633e4-5f37-4e2e-e053-3705fe0a4c80
|
1
|
|
Malignant salivary gland tumours in families with breast cancer susceptibility, file ddc633e4-6075-4e2e-e053-3705fe0a4c80
|
1
|
|
Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: A systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO), file ddc633e4-615b-4e2e-e053-3705fe0a4c80
|
1
|
|
M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy – A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO), file ddc633e4-615d-4e2e-e053-3705fe0a4c80
|
1
|
|
Fatigue, a major still underestimated issue, file ddc633e4-6192-4e2e-e053-3705fe0a4c80
|
1
|
|
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer, file ddc633e4-6242-4e2e-e053-3705fe0a4c80
|
1
|
|
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma, file ddc633e4-62b7-4e2e-e053-3705fe0a4c80
|
1
|
|
Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm, file ddc633e4-64a4-4e2e-e053-3705fe0a4c80
|
1
|
| Totale |
9.634 |